Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
It re enforces the need for vigilance even with svr sustained. Wise ones will not return to alcohol.
COMMENTS BY ALAN FRANCISCUS, EDITOR-IN-CHIEF, HCV ADVOCATE:
This is an important study for testing the durability of an SVR or viral cure and continued disease progression in those with cirrhosis. The results and conclusions of the study include:
There were no cases of relapse once an SVR was achieved.
Improvements in APRI (non-invasive method to gauge disease progression), and biochemical functions in all of the study participants (except 5 patients who had newly acquired hepatitis) occurred in those who were treated.
Importantly, 22.2% of those who had pre-treatment cirrhosis developed liver cancer and 11.1% died of liver related deaths.
The study confirmed two important issuesthe durability of an SVR was maintained in all patients and those patients with pre-treatment cirrhosis can continue to progress on to serious disease which means that people with cirrhosis who achieve an SVR or viral cure must be carefully monitored since the rate of severe disease progression is relatively high.
> those patients with pre-treatment cirrhosis can continue to progress on to serious disease which means that people with cirrhosis who achieve an SVR or viral cure must be carefully monitored since the rate of severe disease progression is relatively high
"patients with pre-treatment cirrhosis can continue to progress on to serious disease which means that people with cirrhosis who achieve an SVR or viral cure must be carefully monitored since the rate of severe disease progression is relatively high. "
The good news here I suppose is that SVR is maintained.
Here's another article:
hepatitiscresearchandnewsupdates.blogspot.com/2011/01/impact-of-sustained-virological.html#.USVe4vL
And another one:
http://hepatitiscresearchandnewsupdates.blogspot.com/2010/11/aasld-long-term-outcomes-better-with.html#.USVhYvLgeSo
Nonetheless, relapse does happen to patients with long term SVR no matter how small the percentage because it does happen as rarely as it is.
Respectfully,
Henry